Hepatits B virus and HIV coinfection management in Perú

Authors

  • Vivian Levy Gladstone Institute of Virology and Immunology, University of California. San Francisco, USA. Médico infectólogo.
  • Robert M. Grant Gladstone Institute of Virology and Immunology, University of California. San Francisco, USA. Médico infectólogo.
  • César Cabezas Instituto Nacional de Salud. Lima, Perú. Instituto de Medicina Tropical “Daniel A. Carrión. Universidad Nacional Mayor de San Marcos. Lima, Perú. Médico infectólogo

DOI:

https://doi.org/10.17843/rpmesp.2007.244.1140

Keywords:

Hepatitis B/ therapy, HIV/AIDS / therapy, Perú

Abstract

In Peru, men who have sex with men (MSM) should be added to the groups at risk for hepatitis B (HBV) infection which include persons from endemic areas, health care workers and commercial sex workers. Given the shared sexual risk factors for transmission, co-infection with HBV and HIV is common in MSM and high risk heterosexuals. The treatment of chronic HBV infection needs to be carefully coordinated with HIV management in HBV-HIV co-infected patients. The main treatment goals for HBV infection are to suppress HBV replication, improve liver function, and minimize the emergence of HBV and HIV drug resistance. In this article, we review the epidemiology of HBV in Peru, the natural history of HBV-HIV co-infection, and describe current treatment options in the Peruvian context.

Downloads

Download data is not yet available.

Downloads

Published

2007-12-30

Issue

Section

Review

How to Cite

1.
Levy V, Grant RM, Cabezas C. Hepatits B virus and HIV coinfection management in Perú. Rev Peru Med Exp Salud Publica [Internet]. 2007 Dec. 30 [cited 2024 Jun. 16];24(4). Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/1140

Most read articles by the same author(s)

1 2 3 4 5 6 > >>